Finding A Fair Profit For Gilead On Coronavirus-Fighting Drug, Remdesivir

Finding a fair profit for Gilead on coronavirus-fighting drug, Remdesivir

CNBC Television

Coronavirus TV Episode 22: Calculating a fair price for remdesivir

Fauci: Gilead's Remdesivir Drug Trials Show ‘Good News' Against Covid-19 Fight

Bloomberg Quicktake

COVID-19: Gilead licensing agreement of Remdesivir | Explained

Gilead's moving quickly with FDA for approval of coronavirus drug remdesivir: CEO

CNBC Television

Gilead Drug Remdesivir Is a Rare Example of Foresight in the Coronavirus Pandemic

Bloomberg Quicktake

Gilead's Remdesivir treatment could see recurring revenue even if a Covid-19 vaccine is found: Jeffe

CNBC International News

Remdesivir: A new drug that boosts recovery from coronavirus l How it works

Hindustan Times

Gilead’s Remdesivir Becomes First Covid-19 Drug to Win FDA Approval

Bloomberg Quicktake

Gilead drug remdesivir proves effective against COVID-19 in US study

US to allow states to distribute Gilead's remdesivir drug to fight COVID-19

WION

BIG STORY | Why Remdesivir trial is significant in fight against COVID-19?

Gilead Sciences Confirms Breakthrough In Anti-COVID Drug Remdesivir

NDTV

Gilead Sciences to donate 1.5M doses of experimental coronavirus drug remdesivir

One America News Network

Optimism for Gilead's drug Remdesivir in treating coronavirus patients may be too premature

Dr. Anthony Fauci's positive comments on using Gilead's Remdesivir to treat coronavirus

CNBC Television

Gilead: Phase 3 study data shows remdesivir helped patients with moderate Covid-19

CNBC Television

Gilead's Virus Drug Remdesivir Gains Approval From FDA

Bloomberg Television

Gilead terminates study after coronavirus drug Remdesivir fails to improve recovery for COVID-19

U.S. FDA gives full approval to Gilead Sciences' antiviral drug remdesivir as COVID-19 treatment